Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Nuclear Medicine Communications, 35, 11, S. 1143-1149
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2014
- Ereignis
-
Veröffentlichung
- (wo)
-
Philadelphia, PA
- (wer)
-
Lippincott Williams & Wilkins
- (wann)
-
2014
- Urheber
-
Wolf, Herta
Bluemel, Christina
Lapa, Constantin Frederik Victor
Muegge, Dirk O.
Kudlich, Theodor
Buck, Andreas K.
Herrmann, Ken
- DOI
-
10.1097/mnm.0000000000000194
- URN
-
urn:nbn:de:bvb:384-opus4-637554
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:42 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wolf, Herta
- Bluemel, Christina
- Lapa, Constantin Frederik Victor
- Muegge, Dirk O.
- Kudlich, Theodor
- Buck, Andreas K.
- Herrmann, Ken
- Universität Augsburg
- Lippincott Williams & Wilkins
Entstanden
- 2014
Ähnliche Objekte (12)
Ein 18F markiertes PET-Radiopharmakon (LMI1195) zur Bildgebung des Norepinephrin-Stoffwechsels im Rattenherz
Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Paralytic subileus as an adverse effect of amino acid–based nephroprotection in a patient undergoing peptide receptor radionuclide therapy
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
The next era of renal radionuclide imaging: novel PET radiotracers
Glauben machen : über deutschsprachige Reiseberichte aus der Sowjetunion (1918 - 1932)
Dose mapping after endoradiotherapy with 177Lu-DOTATATE/DOTATOC by a single measurement after 4 days
OP240 Incidence of hyperkalemia in patients undergoing radiopeptide therapy does not depend on the amount of co-infused amino acid infusion [Abstract]
Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy
Praktiken und Diskursivierung der fotografischen Retusche von 1839-1900
Ein 18F markiertes PET-Radiopharmakon (LMI1195) zur Bildgebung des Norepinephrin-Stoffwechsels im Rattenherz
Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Paralytic subileus as an adverse effect of amino acid–based nephroprotection in a patient undergoing peptide receptor radionuclide therapy
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
The next era of renal radionuclide imaging: novel PET radiotracers
Glauben machen : über deutschsprachige Reiseberichte aus der Sowjetunion (1918 - 1932)
Dose mapping after endoradiotherapy with 177Lu-DOTATATE/DOTATOC by a single measurement after 4 days
OP240 Incidence of hyperkalemia in patients undergoing radiopeptide therapy does not depend on the amount of co-infused amino acid infusion [Abstract]
Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy
Praktiken und Diskursivierung der fotografischen Retusche von 1839-1900
Ein 18F markiertes PET-Radiopharmakon (LMI1195) zur Bildgebung des Norepinephrin-Stoffwechsels im Rattenherz
Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Paralytic subileus as an adverse effect of amino acid–based nephroprotection in a patient undergoing peptide receptor radionuclide therapy
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
The next era of renal radionuclide imaging: novel PET radiotracers
Glauben machen : über deutschsprachige Reiseberichte aus der Sowjetunion (1918 - 1932)
Dose mapping after endoradiotherapy with 177Lu-DOTATATE/DOTATOC by a single measurement after 4 days
OP240 Incidence of hyperkalemia in patients undergoing radiopeptide therapy does not depend on the amount of co-infused amino acid infusion [Abstract]
Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy